AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2011
Jun 15, 2011
30826_dirs_2011-06-15_951dafae-546c-4d6c-a53d-394527d84810.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2011-06-15
Reporting Person: Henry Earl Webb (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-06-15 | Common Stock | P | 1100 | $3.5427 | Acquired | 1100 | Direct |
| 2011-06-15 | Common Stock | P | 3900 | $3.6500 | Acquired | 5000 | Direct |
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23